News & Investors

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Cara Therapeutics Announces Results of Phase 1 Clinical Trial of Novel Analgesic
Cara Therapeutics Announces Results of Phase 1 Clinical Trial of Novel Analgesic Cara Therapeutics, Inc. today announced results of a Phase 1 clinical trial for its peripherally acting kappa opioid agonist, CR665, under development for the treatment of postoperative pain.
View HTML
Toggle Summary Cara Therapeutics Initiates Clinical Trial of Novel Pain Drug Candidate
Cara Therapeutics Initiates Clinical Trial of Novel Pain Drug Candidate Cara Therapeutics, Inc. announced today that it had initiated dosing in a Phase 1 clinical trial for CR665, its novel drug candidate for the treatment of postoperative pain. The single-dose protocol is scheduled to be completed
View HTML